Glucagon-like-peptide-1 agonist therapy in adults with cystic fibrosis
-
Published:2024-08
Issue:
Volume:
Page:
-
ISSN:1569-1993
-
Container-title:Journal of Cystic Fibrosis
-
language:en
-
Short-container-title:Journal of Cystic Fibrosis
Author:
Park SanghoonORCID,
Jain RakshaORCID,
Mirfakhraee SasanORCID
Reference24 articles.
1. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality;Moran;Diabetes Care,2009
2. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American diabetes association and a clinical practice guideline of the cystic fibrosis foundation, endorsed by the pediatric endocrine society;Moran;Diabetes Care,2010
3. Obesity in Cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry;Szentpetery;J Cyst Fibros,2022
4. Glucagon-like peptide 1 in health and disease;Andersen;Nat Rev Endocrinol,2018
5. GIP and GLP-1, the two incretin hormones: similarities and differences;Seino;J Diabetes Investig,2010